Patents by Inventor Jay L. Kelley

Jay L. Kelley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11648042
    Abstract: A method, system and device for securing conductive material on catheter elements for tissue sensing and cryogenic ablation. This may be used to deposit or embed conductive material onto or within polymeric materials. The method of manufacturing a balloon with conductive material may include extruding a polymeric material where the polymeric material includes embedded electrically conductive material. At least a portion of the polymeric material may be removed to expose at least a portion of the embedded electrically conductive material. The benefits may include allowing local bipolar recordings, contact assessment and ice thickness, and compatibility with 3-dimensional electroanatomical mapping systems.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: May 16, 2023
    Assignee: Medtronic CryoCath LP
    Inventor: Jay L. Kelley
  • Publication number: 20210338303
    Abstract: A device, system, and method for performing a variety of treatment procedures safely with a single treatment device. For example, a system is provided that includes a treatment device with a highly conformable balloon that is inflated at a constant pressure and that remains “soft” during use, which enhances balloon-tissue contact, treatment efficacy, and patient safety. In one embodiment, a system for ablating tissue comprises: a treatment device including a highly conformable balloon; a control unit including a fluid supply reservoir in fluid communication with the highly conformable balloon, the control unit being configured to deliver fluid from the fluid supply reservoir to the highly conformable balloon such that the highly conformable balloon is maintained at a balloon pressure of between 0.2 psig and 3.0 psig.
    Type: Application
    Filed: July 14, 2021
    Publication date: November 4, 2021
    Inventors: Jean-Pierre LALONDE, Scott A. HARELAND, Jay L. KELLEY, Rachid MAHROUCHE, Wlodzimierz SADZYNSKI, Megan M. SCHMIDT, Bertin SIMEON, Vladimir TZONEV
  • Publication number: 20210267677
    Abstract: A method and system for mapping tissue and producing lesions for the treatment of cardiac arrhythmias in a non-thermal and optimal manner, minimizing the amount of energy required to selectively stun or ablate the target tissues. Energy may be delivered only at the moment(s) of best device position and proximity of an electrode to target tissue, and only during a time in the cardiac cycle determined to be optimal for reversible or irreversible effects. A method may include determining timing of the cardiac cycle and an optimal time within the cardiac cycle for energy delivery, evaluating proximity between at least one energy delivery electrode and the target tissue, and delivering pulsed field energy from the at least one energy delivery electrode to the target tissue when, during the optimal time for energy delivery, the at least one energy delivery electrode is in close proximity with the target tissue.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 2, 2021
    Inventors: Mark T. STEWART, Catherine R. CONDIE, Jay L. KELLEY
  • Patent number: 11090101
    Abstract: A device, system, and method for performing a variety of treatment procedures safely with a single treatment device. For example, a system is provided that includes a treatment device with a highly conformable balloon that is inflated at a constant pressure and that remains “soft” during use, which enhances balloon-tissue contact, treatment efficacy, and patient safety. In one embodiment, a system for ablating tissue comprises: a treatment device including a highly conformable balloon; a control unit including a fluid supply reservoir in fluid communication with the highly conformable balloon, the control unit being configured to deliver fluid from the fluid supply reservoir to the highly conformable balloon such that the highly conformable balloon is maintained at a balloon pressure of between 0.2 psig and 3.0 psig.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: August 17, 2021
    Assignee: Medtronic CryoCath LP
    Inventors: Jean-Pierre Lalonde, Scott A. Hareland, Jay L. Kelley, Rachid Mahrouche, Wlodzimierz Sadzynski, Megan M. Schmidt, Bertin Simeon, Vladimir Tzonev
  • Patent number: 11033329
    Abstract: A method and system for mapping tissue and producing lesions for the treatment of cardiac arrhythmias in a non-thermal and optimal manner, minimizing the amount of energy required to selectively stun or ablate the target tissues. Energy may be delivered only at the moment(s) of best device position and proximity of an electrode to target tissue, and only during a time in the cardiac cycle determined to be optimal for reversible or irreversible effects. A method may include determining timing of the cardiac cycle and an optimal time within the cardiac cycle for energy delivery, evaluating proximity between at least one energy delivery electrode and the target tissue, and delivering pulsed field energy from the at least one energy delivery electrode to the target tissue when, during the optimal time for energy delivery, the at least one energy delivery electrode is in close proximity with the target tissue.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: June 15, 2021
    Assignee: Medtronic Ablation Frontiers LLC
    Inventors: Mark T. Stewart, Catherine R. Condie, Jay L. Kelley
  • Publication number: 20190336192
    Abstract: A device, system, and method for performing a variety of treatment procedures safely with a single treatment device. For example, a system is provided that includes a treatment device with a highly conformable balloon that is inflated at a constant pressure and that remains “soft” during use, which enhances balloon-tissue contact, treatment efficacy, and patient safety. In one embodiment, a system for ablating tissue comprises: a treatment device including a highly conformable balloon; a control unit including a fluid supply reservoir in fluid communication with the highly conformable balloon, the control unit being configured to deliver fluid from the fluid supply reservoir to the highly conformable balloon such that the highly conformable balloon is maintained at a balloon pressure of between 0.2 psig and 3.0 psig.
    Type: Application
    Filed: May 2, 2018
    Publication date: November 7, 2019
    Inventors: Jean-Pierre LALONDE, Scott A. HARELAND, Jay L. KELLEY, Rachid MAHROUCHE, Wlodzimierz SADZYNSKI, Megan M. SCHMIDT, Bertin SIMEON, Vladimir TZONEV
  • Publication number: 20190216525
    Abstract: A method and system for mapping tissue and producing lesions for the treatment of cardiac arrhythmias in a non-thermal and optimal manner, minimizing the amount of energy required to selectively stun or ablate the target tissues. Energy may be delivered only at the moment(s) of best device position and proximity of an electrode to target tissue, and only during a time in the cardiac cycle determined to be optimal for reversible or irreversible effects. A method may include determining timing of the cardiac cycle and an optimal time within the cardiac cycle for energy delivery, evaluating proximity between at least one energy delivery electrode and the target tissue, and delivering pulsed field energy from the at least one energy delivery electrode to the target tissue when, during the optimal time for energy delivery, the at least one energy delivery electrode is in close proximity with the target tissue.
    Type: Application
    Filed: March 20, 2019
    Publication date: July 18, 2019
    Inventors: Mark T. STEWART, Catherine R. CONDIE, Jay L. KELLEY
  • Patent number: 10271893
    Abstract: A method and system for mapping tissue and producing lesions for the treatment of cardiac arrhythmias in a non-thermal and optimal manner, minimizing the amount of energy required to selectively stun or ablate the target tissues. Energy may be delivered only at the moment(s) of best device position and proximity of an electrode to target tissue, and only during a time in the cardiac cycle determined to be optimal for reversible or irreversible effects. A method may include determining timing of the cardiac cycle and an optimal time within the cardiac cycle for energy delivery, evaluating proximity between at least one energy delivery electrode and the target tissue, and delivering pulsed field energy from the at least one energy delivery electrode to the target tissue when, during the optimal time for energy delivery, the at least one energy delivery electrode is in close proximity with the target tissue.
    Type: Grant
    Filed: March 20, 2015
    Date of Patent: April 30, 2019
    Assignee: Medtronic Ablation Frontiers LLC
    Inventors: Mark T. Stewart, Catherine R. Condie, Jay L. Kelley
  • Publication number: 20180221077
    Abstract: A method, system and device for securing conductive material on catheter elements for tissue sensing and cryogenic ablation. This may be used to deposit or embed conductive material onto or within polymeric materials. The method of manufacturing a balloon with conductive material may include extruding a polymeric material where the polymeric material includes embedded electrically conductive material. At least a portion of the polymeric material may be removed to expose at least a portion of the embedded electrically conductive material. The benefits may include allowing local bipolar recordings, contact assessment and ice thickness, and compatibility with 3-dimensional electroanatomical mapping systems.
    Type: Application
    Filed: February 5, 2018
    Publication date: August 9, 2018
    Inventor: Jay L. KELLEY
  • Publication number: 20160166310
    Abstract: A method and system for mapping tissue and producing lesions for the treatment of cardiac arrhythmias in a non-thermal and optimal manner, minimizing the amount of energy required to selectively stun or ablate the target tissues. Energy may be delivered only at the moment(s) of best device position and proximity of an electrode to target tissue, and only during a time in the cardiac cycle determined to be optimal for reversible or irreversible effects. A method may include determining timing of the cardiac cycle and an optimal time within the cardiac cycle for energy delivery, evaluating proximity between at least one energy delivery electrode and the target tissue, and delivering pulsed field energy from the at least one energy delivery electrode to the target tissue when, during the optimal time for energy delivery, the at least one energy delivery electrode is in close proximity with the target tissue.
    Type: Application
    Filed: March 20, 2015
    Publication date: June 16, 2016
    Inventors: Mark T. STEWART, Catherine R. CONDIE, Jay L. KELLEY
  • Publication number: 20130288218
    Abstract: A resilient model of a heart's atria and associated vasculature is disclosed. The model is generated from CT scans of patients' with varying cardiac anatomies. The model is connected to a temperature-controlled fluid reservoir and a pump that periodically circulates fluid through the cardiac model. The model provides a visual indication of temperature change. The model may be used to simulate endocardial procedures such as pulmonary vein isolation for treatment of atrial fibrillation.
    Type: Application
    Filed: January 30, 2013
    Publication date: October 31, 2013
    Applicant: MEDTRONIC CRYOCATH LP
    Inventors: George D. Mallin, Jay L. Kelley, Christopher D. Rolfes, Alexander T. Ryan